151 related articles for article (PubMed ID: 36052068)
21. Histological features of melanoma sentinel lymph node metastases associated with status of the completion lymphadenectomy and rate of subsequent relapse.
Govindarajan A; Ghazarian DM; McCready DR; Leong WL
Ann Surg Oncol; 2007 Feb; 14(2):906-12. PubMed ID: 17136471
[TBL] [Abstract][Full Text] [Related]
22. Lymphatic flow is mostly preserved after sentinel lymph node biopsy in primary cutaneous malignant melanoma.
Yokota K; Sawada M; Matsumoto T; Hasegawa Y; Kono M; Akiyama M
J Dermatol Sci; 2015 May; 78(2):101-7. PubMed ID: 25771166
[TBL] [Abstract][Full Text] [Related]
23. Histomorphologic parameters and CXCR4 mRNA and protein expression in sentinel node melanoma metastasis are correlated to clinical outcome.
Franco R; Cantile M; Scala S; Catalano E; Cerrone M; Scognamiglio G; Pinto A; Chiofalo MG; Caracò C; Anniciello AM; Abbruzzese A; Caraglia M; Botti G
Cancer Biol Ther; 2010 Mar; 9(6):423-9. PubMed ID: 20061818
[TBL] [Abstract][Full Text] [Related]
24. Implications of lymphatic drainage to unusual sentinel lymph node sites in patients with primary cutaneous melanoma.
Sumner WE; Ross MI; Mansfield PF; Lee JE; Prieto VG; Schacherer CW; Gershenwald JE
Cancer; 2002 Jul; 95(2):354-60. PubMed ID: 12124836
[TBL] [Abstract][Full Text] [Related]
25. Adjuvant therapy of malignant melanoma and the role of sentinel node mapping.
Eggermont AM
Recent Results Cancer Res; 2000; 157():178-89. PubMed ID: 10857171
[TBL] [Abstract][Full Text] [Related]
26. Patterns of initial recurrence and prognosis after sentinel lymph node biopsy and selective lymphadenectomy for melanoma.
Wagner JD; Ranieri J; Evdokimow DZ; Logan T; Chuang TY; Johnson CS; Jung SH; Wenck S; Coleman JJ
Plast Reconstr Surg; 2003 Aug; 112(2):486-97. PubMed ID: 12900606
[TBL] [Abstract][Full Text] [Related]
27. Adjuvant Therapy is Effective for Melanoma Patients with a Positive Sentinel Lymph Node Biopsy Who Forego Completion Lymphadenectomy.
Farrow NE; Raman V; Williams TP; Nguyen KY; Tyler DS; Beasley GM
Ann Surg Oncol; 2020 Dec; 27(13):5121-5125. PubMed ID: 32314157
[TBL] [Abstract][Full Text] [Related]
28. Validation of a scoring system to predict non-sentinel lymph node metastasis in melanoma.
Cadili A; McKinnon G; Wright F; Hanna W; Macintosh E; Abhari Z; Dabbs K
J Surg Oncol; 2010 Mar; 101(3):191-4. PubMed ID: 20039281
[TBL] [Abstract][Full Text] [Related]
29. Evidence for a better nodal staging system for melanoma: the clinical relevance of metastatic disease confined to the sentinel lymph nodes.
Reintgen M; Murray L; Akman K; Giuliano R; Lozicki A; Shivers S; Reintgen D
Ann Surg Oncol; 2013 Feb; 20(2):668-74. PubMed ID: 23054112
[TBL] [Abstract][Full Text] [Related]
30. Complete lymph node dissection or observation in melanoma patients with multiple positive sentinel lymph nodes: A single-center retrospective analysis.
Persa OD; Knuever J; Mauch C; Schlaak M
J Dermatol; 2018 Oct; 45(10):1191-1194. PubMed ID: 30095864
[TBL] [Abstract][Full Text] [Related]
31. Optimal detection of sentinel lymph node metastases by intraoperative radioactive threshold and molecular analysis in patients with melanoma.
Manca G; Romanini A; Pellegrino D; Borsò E; Rondini M; Orlandini C; Zucchi V; Pasqualetti F; Mariani G
J Nucl Med; 2008 Nov; 49(11):1769-75. PubMed ID: 18927334
[TBL] [Abstract][Full Text] [Related]
32. Surgical management of the groin lymph nodes in melanoma in the era of sentinel lymph node dissection.
Essner R; Scheri R; Kavanagh M; Torisu-Itakura H; Wanek LA; Morton DL
Arch Surg; 2006 Sep; 141(9):877-82; discussion 882-4. PubMed ID: 16983031
[TBL] [Abstract][Full Text] [Related]
33. Factors predictive of pelvic lymph node involvement and outcomes in melanoma patients with metastatic sentinel lymph node of the groin: A multicentre study.
Mozzillo N; Pasquali S; Santinami M; Testori A; Di Marzo M; Crispo A; Patuzzo R; Verrecchia F; Botti G; Montella M; Rossi CR; Caracò C
Eur J Surg Oncol; 2015 Jul; 41(7):823-9. PubMed ID: 25800935
[TBL] [Abstract][Full Text] [Related]
34. Correlation of Tumor Burden in Sentinel Lymph Nodes with Tumor Burden in Nonsentinel Lymph Nodes and Survival in Cutaneous Melanoma.
Namikawa K; Aung PP; Milton DR; Tetzlaff MT; Torres-Cabala CA; Curry JL; Nagarajan P; Ivan D; Ross M; Gershenwald JE; Prieto VG
Clin Cancer Res; 2019 Dec; 25(24):7585-7593. PubMed ID: 31570567
[TBL] [Abstract][Full Text] [Related]
35. Patterns of recurrence after sentinel lymph node biopsy for cutaneous melanoma.
Fincher TR; McCarty TM; Fisher TL; Preskitt JT; Lieberman ZH; Stephens JF; O'Brien JC; Kuhn JA
Am J Surg; 2003 Dec; 186(6):675-81. PubMed ID: 14672778
[TBL] [Abstract][Full Text] [Related]
36. [Sentinel lymph node dissection in patients with malignant melanoma. Diagnostic and therapeutic standards].
Arens A; Osinga J; Schwipper V; Schober O; Tilkorn H; Liebau J
Chirurg; 2003 Jul; 74(7):665-70. PubMed ID: 12883795
[TBL] [Abstract][Full Text] [Related]
37. Sentinel node tumor burden in cutaneous melanoma. Survival with competing risk analysis and influence in relapses and non-sentinel node status: retrospective cohort study with long follow-up in a Spanish population.
Loidi-Pascual L; Librero J; Córdoba-Iturriagagoitia A; Guarch-Troyas R; Montes-Díaz M; Ruiz de Azua-Ciria Y; Arozarena I; Goñi-Gironés E; Yanguas I
Arch Dermatol Res; 2022 May; 314(4):369-378. PubMed ID: 33973061
[TBL] [Abstract][Full Text] [Related]
38. Multiple Lymph Node Basin Drainage in Trunk Melanoma Is Not Associated with Survival of Sentinel Lymph Node-Positive Patients.
Ribero S; Osella Abate S; Pasquali S; Rossi CR; Borgognoni L; Piazzalunga D; Solari N; Schiavon M; Brandani P; Ansaloni L; Ponte E; Silan F; Sommariva A; Bellucci F; Macripò G; Quaglino P;
Dermatology; 2017; 233(2-3):205-211. PubMed ID: 28738392
[TBL] [Abstract][Full Text] [Related]
39. Clinicopathologic models predicting non-sentinel lymph node metastasis in cutaneous melanoma patients: Are they useful for patients with a single positive sentinel node?
Rentroia-Pacheco B; Tjien-Fooh FJ; Quattrocchi E; Kobic A; Wever R; Bellomo D; Meves A; Hieken TJ
J Surg Oncol; 2022 Mar; 125(3):516-524. PubMed ID: 34735719
[TBL] [Abstract][Full Text] [Related]
40. Characterization of micrometastatic disease in melanoma sentinel lymph nodes by enhanced pathology: recommendations for standardizing pathologic analysis.
Spanknebel K; Coit DG; Bieligk SC; Gonen M; Rosai J; Klimstra DS
Am J Surg Pathol; 2005 Mar; 29(3):305-17. PubMed ID: 15725798
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
